Farther Finance Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Farther Finance Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-104	Closed	-$2.24K	–	5762
2025 Q4	$2.24K	Buy	104 +89	+593%	+$1.73K	﹤0.01%	4649
2025 Q3	$229	Buy	+15	New	+$195	﹤0.01%	4695

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Farther Finance Advisors's AVDL Position: Q1 2026 in Review

Farther Finance Advisors sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 104 shares — an estimated $2.24K sold.

Farther Finance Advisors first reported a position in AVDL in Q3 2025 and held it in 2 quarters. The position peaked at $2.24K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Farther Finance Advisors reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Farther Finance Advisors sold 104 Avadel Pharmaceuticals shares in Q1 2026, an estimated $2.24K.
Farther Finance Advisors first reported a position in Avadel Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Farther Finance Advisors's Avadel Pharmaceuticals position peaked at $2.24K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.